Cargando…
Impact of the COVID-19 pandemic on hepatitis C outcomes at a health-system specialty pharmacy
BACKGROUND: The goal of hepatitis C virus (HCV) treatment is to cure the patient of the infection, defined as a nondetectable HCV RNA at least 12 weeks after treatment completion, or sustained virologic response (SVR). The COVID-19 pandemic has presented new barriers to care in the treatment of pati...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Academy of Managed Care Pharmacy
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10372976/ https://www.ncbi.nlm.nih.gov/pubmed/35621721 http://dx.doi.org/10.18553/jmcp.2022.28.6.667 |